Loading…

Shield AI has agreed to acquire Echodyne in a transaction valued at up to $5.3 billion, comprising $4.8 billion at closing and up to $500 million contingent on performance targets. Shield is raising $2.5 billion to support the acquisition.
“Shield has agreed to acquire Echodyne in a transaction valued at up to $5.3 billion.”airframer.com
Summarized from public sources; check the original articles before acting on it.